USPTO 2015–2025 USPTO PatentsView US Corporation

Hemotek, LLC

USPTO PatentsView assignee record - 6 granted patents across 8 technology areas, recorded in grant years 2019–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C10L (Fuels NOT Otherwise Provided FOR; Natural GAS; Synthetic Natural GAS Obtained BY Processes NOT Covered BY Subclasses C10g OR C10K; Liquified Petroleum GAS; USE OF Additives TO Fuels OR FIRES; Fire-lig).

RSS updates for this company

The verdict

According to USPTO PatentsView, Hemotek ranks #40,683 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 8 technology areas.

#40,683
of 49,997 US assignees by volume
33rd percentile
by Innovation Score (30.1/100)
16.7
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R40683 · US Corporation #40,683 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 6 grants
  • LOWER-Q #40,683/49,997
  • PHOTO-FINISH Heemskerk Vasteplant…
  • CPC-NARROW C10L · 8 areas
  • INNOV-THIN 30.1/100
  • CLAIMS-RICH 16.7 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Heemskerk Vasteplanten BV (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Hemotek

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Hemotek's Innovation Score is 30.1/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Hemotek's grants concentrate

Hemotek, LLC is a focused PatentsView assignee: 8 CPC subclasses with 50% of grants classified under C10L (Fuels NOT Otherwise Provided FOR; Natural GAS; Synthetic Natural GAS Obtained BY Processes NOT Covered BY Subclasses C10g OR C10K; Liquified Petroleum GAS; USE OF Additives TO Fuels OR FIRES; Fire-lig). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2020. By volume, Hemotek sits between Heemskerk Vasteplanten BV and Herostone Quartz Surfaces Inc.

Hemotek's three-year grant acceleration

Hemotek, LLC shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Hemotek's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Hemotek holds 6 patents at rank #40,626, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Hemotek

By rank, the assignees closest to #40,626 in granted patent volume.

Leaders in C10L (Fuels)

Other assignees with the most granted patents in Hemotek's primary technology class.

Hemotek's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 2019202020212022 2
USPTO utility patent grants by year · 2019–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Hemotek, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 33.3%
2020 1 16.7%
2021 1 16.7%
2022 2 33.3%

Where it ranks

Overall rank by patents

#40,683

of 49,997 tracked assignees

Innovation Score

30.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Hemotek, LLC's patent record in context - here's where to go next.

  • Hemotek, LLC's lead technology class is C10L (Fuels NOT Otherwise Provided FOR; Natural GAS; Synthetic Natural GAS Obtained BY Processes NOT Covered BY Subclasses C10g OR C10K; Liquified Petroleum GAS; USE OF Additives TO Fuels OR FIRES; Fire-lig), 50% of its portfolio - see every assignee active in that class. Explore C10L
  • Ranked #40,683 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Hemotek, LLC against Heemskerk Vasteplanten BV, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.